7Baggers

Prelude Therapeutics Quarterly Cash Flow Statements Chart

Quarterly
 | 
Annual
 
 Operating Cashflow  
 Investing Cashflow  
 Financing Cashflow  
 Capital Expenditure  
20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -260.63-192.29-123.95-55.6112.7381.07149.41217.75Milllion

Prelude Therapeutics Quarterly Cash Flow Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 
  net cash from operating activities-23,578,000 -25,683,000 -27,668,000 -30,134,000 -22,927,000 -20,439,000 -18,468,000 -21,895,000 -25,702,000 -21,774,000 -19,912,000 -16,143,000 -14,847,000 -12,507,000 -8,902,000 -9,921,000 -8,469,000 
  net cash from investing activities7,736,000 15,045,000 -75,426,000 17,999,000 1,355,000 21,607,000 58,576,000 153,000 -1,804,000 -260,632,000 -381,000 -986,000 -329,000 -170,000 -42,000 -80,000 -199,000 
  net cash from financing activities25,237,000 88,000 111,339,000 -269,000 155,000 148,000 -41,036,000 41,548,000 1,954,000 711,000 422,000 161,810,000 -1,307,000 217,753,000 -65,000 29,847,000 -93,000 
  capital expenditure-1,129,000 -591,000 -983,000 -810,000 -393,000 -916,000 -758,000 -952,000 -297,000 -659,000 -381,000 -986,000 -329,000 -170,000 -42,000 -80,000 -199,000 

We provide you with 20 years of cash flow statements for Prelude Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Prelude Therapeutics stock. Explore the full financial landscape of Prelude Therapeutics stock with our expertly curated income statements.

The information provided in this report about Prelude Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.